Larvol Delta - Clarity-receives-US-FDA-Fast-Track-Designation-for-the-treatment-of-metastatic-castrationresistant-prostate-cancer-patients-with-Cu67-SARbisPSMA

67Cu-SAR-bisPSMA - Clarity Pharma

https://www.prnewswire.com/news-releases/clarity-receives-us-fda-fast-track-designation-for-the-treatment-of-metastatic-castration-resistant-prostate-cancer-patients-with-cu-67-sar-bispsma-302379766.html

Feb 19, 2025

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next